Patents by Inventor Paul S. Aisen

Paul S. Aisen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING AND PREVENTING NEUROLOGICAL DISORDERS USING DOCOSAHEXAENOIC ACID
    Publication number: 20110177061
    Abstract: The disclosure relates to methods of treating or preventing neurological disorders using docosahexaenoic acid.
    Type: Application
    Filed: July 9, 2010
    Publication date: July 21, 2011
    Applicant: MARTEK BIOSCIENCES CORPORATION
    Inventors: Paul S. AISEN, Joseph F. Quinn, Karin Yurko-Mauro
  • Treatment of neurodegenerative conditions with nimesulide
    Patent number: 7226948
    Abstract: The present invention relates to the use of nimesulide and structurally related compounds in the prevention and/or treatment of neurodegenerative conditions. It is based, at least in part, on the discovery that nimesulide exhibits a neuroprotective effect against ?-amyloid induced cell death. Without being bound to any particular theory, it appears that nimesulide inhibits a non-inflammatory mechanism of neurodegeneration.
    Type: Grant
    Filed: May 17, 2002
    Date of Patent: June 5, 2007
    Assignee: University of Mount Sinai School of Medicine of the City of New York
    Inventors: Giulio M. Pasinetti, Paul S. Aisen
  • TRANSGENIC MOUSE EXPRESSING THE HUMAN CYCLOOXYGENASE-2 GENE AND NEURONAL CELL CULTURES DERIVED THEREFROM
    Publication number: 20020162130
    Abstract: The present invention relates to the use of nimesulide and structurally related compounds in the prevention and/or treatment of neurodegenerative conditions. It is based, at least in part, on the discovery that nimesulide exhibits a neuroprotective effect against &bgr.
    Type: Application
    Filed: July 16, 1999
    Publication date: October 31, 2002
    Inventors: GIULIO M. PASINETTI, PAUL S. AISEN
  • Treatment of neurodegenerative conditions with nimesulide
    Patent number: 5985930
    Abstract: The present invention relates to the use of nimesulide and structurally related compounds in the prevention and/or treatment of neurodegenerative conditions. It is based, at least in part, on the discovery that nimesulide exhibits a neuroprotective effect against .beta.-amyloid induced cell death. Without being bound to any particular theory, it appears that nimesulide inhibits a non-inflammatory mechanism of neurodegeneration.
    Type: Grant
    Filed: April 1, 1997
    Date of Patent: November 16, 1999
    Inventors: Giulio M. Pasinetti, Paul S. Aisen